The Center for Cancer and Blood Disorders (CCBD), a network of community-based oncology practices across Maryland, has launched a program to make CAR…
Myeloma
Have you seen “The Pitt?” The medical drama on HBO Max is not for the faint of heart as it races from case…
It started with bruises on my mum’s arms. They were small, purple, and red, as if she had fallen down. While we were still trying…
The U.S. Food and Drug Administration (FDA) has granted fast track status to Opna Bio‘s OPN-6602 as a potential treatment for people…
Note: This column describes the author’s experience with several multiple myeloma treatments. Not everyone will have the same response to treatment. Consult your doctor before…
Her name badge looked so common and ordinary; it was a tiny, plastic square attached to the hem of a pocket on her scrubs. But…
I used to pride myself on my memory. Growing up, I remembered every detail of things that happened. Sometimes I would – very annoyingly —…
I can vividly recall an incident that occurred inside the infusion room one day last November. It was the third hour of a four-hour drip…
The first patient has been dosed in a Phase 2 trial testing an all-oral, triple-combination treatment that includes Cellcentric’s investigational therapy inobrodib in people…
A few weeks ago, I wrote about the annual challenge I face during the season of Lent: the temptation of Thin Mints. The Thin…
Recent Posts
- FDA approves cell therapy to reduce GVHD risk after transplant
- Regulators in 2 countries OK clinical testing of new blood cancer treatment
- The changing details of my mother’s hands tell her life story
- Glioblastoma trial adds new drug in search for better treatments
- Protein marker may help predict myeloma outcomes
